STOCKS / Finance

Illumina, Inc. (ILMN) Stock Up on $100 Human Genome Sequencing Plans

From InvestorPlaceHot Stocks - Investment Strategies - Market Insight | InvestorPlace
January 10, 2017 - 12:23pm

InvestorPlaceInvestorPlace - Stock Market News, Stock Advice & Trading Tips Illumina, Inc. (ILMN) shares are up as the company announced a $100 human genome sequencing plan called NovaSeq Series. The stock has been doing well recently. The post Illumina, Inc. (ILMN) Stock Up on $100 Human Genome Sequencing Plans appeared first on InvestorPlace.



Continue reading this article »